Artist Natalia Padilla, founder of Dsgn For Us, poses for a photo with her project, “YELLOW,” an interactive paper installation, at Arts Mission in Oak Cliff, Thursday, March 21, 2024.

Design Therapeutics Inc (NASDAQ:DSGN) announces Q3 2023 financial results with a net loss of $15.8 million.DSGN's cash reserves of approximately $290 million expected to support operations through ...

Net Loss: Reported a net loss of $11.8 million for Q4 and $66.9 million for the full year 2023. R&D and G&A Expenses: R&D expenses of $57.1 million and G&A expenses of $21.1 million for the year ...

Dsgn For Us volunteer Nick Denman of Austin, takes photos of their project, “YELLOW,” an interactive paper installation, at Arts Mission in Oak Cliff, Thursday, March 21, 2024.